🇺🇸 FDA
Patent

US 12123002

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

granted A61PA61P21/02A61P25/28

Quick answer

US patent 12123002 (Compositions and methods of treating amyotrophic lateral sclerosis (ALS)) held by VOYAGER THERAPEUTICS, INC. expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Oct 22 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P21/02, A61P25/28, A61P43/00